Mark Bonyhadi

Mark Bonyhadi

Keine laufenden Positionen mehr
72 Jahre
Health Technology
Consumer Services
Health Services

Profil

Mark L.
Bonyhadi
served as the Chairman of the American Society of Gene & Cell Therapy.
He was the Director-Global Business Development at Life Technologies Ltd. from 2006 to 2013.
Dr. Bonyhadi also worked as an Independent Director at TC Biopharm (Holdings) Plc from 2022 to 2024.
Prior to that, he was the Vice President-Research & Development at Xcyte Therapies, Inc. from 1997 to 2006.
From 2013 to 2018, he held the position of Vice President-Research & Head-Academic Affairs at Juno Therapeutics, Inc. Dr. Bonyhadi was also a Senior Scientist at Systemix, Inc. He served as a Senior Advisor at Qiming US Ventures Management, LLC from 2018 to 2022.
Dr. Bonyhadi obtained his undergraduate degree from The Reed Institute in 1982 and his doctorate degree from the University of California, Berkeley in 1990.

Ehemalige bekannte Positionen von Mark Bonyhadi

UnternehmenPositionEnde
TC BIOPHARM (HOLDINGS) PLC Direktor/Vorstandsmitglied 26.06.2024
Berater 31.12.2022
Technik-/Wissenschafts-/F&E-Leiter 12.10.2021
JUNO THERAPEUTICS INC Corporate Officer/Principal 01.01.2018
Corporate Officer/Principal 01.01.2013
Sehen Sie sich die Erfahrung von Mark Bonyhadi im Detail an

Ausbildung von Mark Bonyhadi

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

81

Beziehungen ersten Grades

9

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen9

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

  1. Börse
  2. Insiders
  3. Mark Bonyhadi